Drug Trial Radar · NCT03030599
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Last checked: Nov 19, 2026Latest source record: Nov 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
201
Actual
Start
Mar 14, 2017
Primary completion
Jan 24, 2019
Study completion Jul 10, 2019
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Jan 25, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.
Conditions
- Narcolepsy With Cataplexy
Interventions
JZP-258Drug
JZP-258 oral solution 0.5 g/mL, which is equivalent to 0.413 g/mL of oxybate
PlaceboOther
Matching placebo solution (aqueous solution containing sodium citrate, malic acid, and sucralose; all ingredients were compendial \[United States Pharmacopeia/ National Formulary\])
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Weekly Number of Cataplexy AttacksTime frame: Change from baseline (2 weeks of the Stable Dose Period) to the 2 weeks of the Double Blind Randomized Withdrawal Period (DB RWP)
Locations
25 sites in 6 countries. Site status is shown where the registry gives one.
SDS Clinical Trials, Inc.
Orange, California
Stanford Health Services
Stanford, California
Colorado Sleep Institute
Boulder, Colorado
Pulmonary Disease Specialists
Kissimmee, Florida
Fort Wayne Neurological Center
Fort Wayne, Indiana
Kentucky Research Group
Louisville, Kentucky
Center for Sleep & Wake Disorders
Chevy Chase, Maryland
Montefiore/ Sleep-Wake Disorders Center
The Bronx, New York
Gastonia Medical Specialty Clinic
Gastonia, North Carolina
Research Carolina
Huntersville, North Carolina
Intrepid Research
Cincinnati, Ohio
Cleveland Clinic, Sleep Disorder Center
Cleveland, Ohio
UZ Antwerpen
Edegem, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
Fakultni nemocnice Ostrava
Ostrava-Poruba, Czechia
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
Helsingin Uniklinikka, Vitalmed Oy
Helsinki, Finland
Hopital Roger Salengro - CHU Lille
Lille, France
Hôpital Gui de Chauliac
Montpellier, Herault, France
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital Clinic i Provincial de Barcelona
Barcelona, Spain
Hospital General de Castellón
Castelló, Spain
Instituto de Investigaciones del Sueño
Madrid, Spain
Hospital Vithas Nuestra Señora de America
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.